American International Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-37,564
Closed -$1.03K 3158
2021
Q2
$1.03K Sell
37,564
-2,163
-5% -$42.5K ﹤0.01% 1497
2021
Q1
$655 Buy
39,727
+105
+0.3% +$2.39K ﹤0.01% 1694
2020
Q4
$730 Sell
39,622
-1,137
-3% -$20.3K ﹤0.01% 1561
2020
Q3
$555K Buy
40,759
+9,809
+32% +$151K ﹤0.01% 1547
2020
Q2
$555K Buy
30,950
+10,446
+51% +$158K ﹤0.01% 1539
2020
Q1
$204K Sell
20,504
-1,184
-5% -$9.7K ﹤0.01% 1893
2019
Q4
$177K Buy
21,688
+3,140
+17% +$29K ﹤0.01% 2295
2019
Q3
$184K Sell
18,548
-129
-0.7% -$1.22K ﹤0.01% 2220
2019
Q2
$236K Sell
18,677
-159
-0.8% -$1.68K ﹤0.01% 2127
2019
Q1
$192K Buy
18,836
+12,381
+192% +$94.9K ﹤0.01% 2231
2018
Q4
$48K Sell
6,455
-50
-0.8% -$366 ﹤0.01% 2899
2018
Q3
$65K Buy
+6,505
New +$75.7K ﹤0.01% 3004

American International Group's TBIO Position: Q3 2021 in Review

American International Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 37,564 shares — an estimated $1.03K sold.

American International Group first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $555K in Q3 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • American International Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • American International Group sold 37,564 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.03K.
  • American International Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • American International Group's Translate Bio, Inc. Common Stock position peaked at $555K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on American International Group's 13F filing for Q3 2021, filed 12 Nov 2021.